A biotechnology company developing gene-edited therapies for bacterial infections in the gut received a U.S. patent for viruses engineered as treatments. . . . → Read More: Patent Issued for Crispr-Edited Viruses in Microbiome
|
|||||
       
 |
A new company is acquiring a technology using genome-edited tadpoles that finds current drugs addressing precise genetic conditions underlying rare diseases. . . . → Read More: Start-Up Licenses Gene-Edited Drug Discovery Tech. 
A genetic technology for synthesizing cannabinoid compounds without cannabis cells was licensed to a company spun-off from the lab that developed the process. . . . → Read More: Cannabinoid Synthesis Process Licensed to Spin-Off Company  Comments are closed  Intellectual property, New products  biomedical, biotechnology, chemistry, entrepreneurs, genomics, Israel, licensing, life sciences, pharmaceuticals, physical sciences, university 
Two companies agreed to license technologies from academic labs in the U.S. and U.K. for developing faster and more sensitive at-home tests for Covid-19 infections. . . . → Read More: Univ. Labs Ink Licensing Deals for Covid-19 Tests Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, Covid-19, entrepreneurs, genomics, licensing, life sciences, medical device, physical sciences, U.K., university 
A biotechnology company received a patent for its engineered viruses to deliver gene-edited treatments to combat bacterial infections in the microbiome. . . . → Read More: Patent Issued for Anti-Bacterial Viruses with Crispr Payloads Comments are closed Intellectual property biomedical, biotechnology, cancer, Europe, genomics, life sciences, patent, pharmaceuticals, USPTO 
Two companies working in women’s reproductive health are developing a new non-hormonal contraceptive that works in cervical mucous membranes. . . . → Read More: Women’s Health Companies Partner on New Contraceptive Comments are closed Intellectual property, Joint ventures/collaborations biomedical, biotechnology, challenge, entrepreneurs, Europe, licensing, life sciences, medical device, NIH, pharmaceuticals, preclinical 
A biotechnology company is licensing a gene-editing enzyme to Novartis to create treatments for inherited blood disorders such as sickle cell disease. . . . → Read More: Biotech in $1.5B Gene-Editing Tech License Deal Comments are closed Intellectual property, New products biomedical, biotechnology, Europe, genomics, licensing, life sciences, pharmaceuticals 
A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device Comments are closed Finance, Intellectual property, Joint ventures/collaborations biomedical, biotechnology, Canada, equity, Europe, investment, licensing, life sciences, medical device, stem cells 
A company developing a needle patch for vaccine delivery is acquiring the rights to a synthetic SARS-Cov-2 spike protein for its Covid-19 vaccine patch. . . . → Read More: Univ. Lab Licenses Protein for Vaccine Patch Comments are closed Intellectual property, New products biomedical, biotechnology, chemistry, clinical trials, Covid-19, engineering, licensing, life sciences, medical device, pharmaceuticals, physical sciences, preclinical, university 
A biotechnology company discovering protein therapies in fungi is collaborating with drug maker GlaxoSmithKline to find new small molecule drugs. . . . → Read More: Drug Discovery Biotech Inks Partnering Deal, Gains $175M 3 comments - (Comments are closed) Finance, Intellectual property biomedical, biotechnology, cancer, chemistry, entrepreneurs, equity, genomics, licensing, life sciences, mathematics, pharmaceuticals, physical sciences, preclinical, university, venture capital |
|
|||
|
Copyright © 2022 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
